Category Archives: The IPO Buzz

May begins with a big IPO in focus. Bausch + Lomb Corp. (BLCO proposed), the global eye care company, is going public this week with an IPO likely to raise $787.5 million – making it the second-biggest IPO of 2022.  Only TPG, Inc. (TPG), the private equity king, was bigger – with its $1 billion […]

Vaccine maker HilleVax, Inc. (HLVX proposed) hopped on to the IPO Express early today for its last run in April 2022. This is the first sizable IPO from big banks since Excelerate Energy (EE) made its successful debut on April 13th.  J.P Morgan, SVB Leerink, Stifel and Guggenheim Securities are the joint book-runners for the […]

Singapore-based JE Cleantech Holdings Limited (JCSE) took off like a rocket in its NASDAQ debut on Earth Day (Friday, April 22, 2022). Shares of JE Cleantech shot up over 370 percent on Friday afternoon in their first day of trading on the NASDAQ – surging to $18.84 from their IPO price of $4.00. JE Cleantech’s […]

The IPO market is quiet. Many on Wall Street are out for an extended spring holiday break with the convergence this year of Passover, Easter and the beginning of Ramadan. Only a handful of tiny IPOs are on the IPO Calendar for pricing later this week. (Please see the IPO Calendar.) IPOScoop is taking a […]

Excelerate Energy (EE proposed) brought some heat to the April IPO Calendar by launching its IPO early today. The liquefied natural gas (LNG) company plans to offer 16 million shares at $21 to $24 to raise $360 million in its IPO, set for pricing next week – on Tuesday night, April 12. The stock is […]

Rail Vision Ltd., an Israeli tech start-up focused on rail safety, crashed as it pulled out of the IPO station on Thursday. The stock fell 24 percent when it opened Thursday (March 31) on the NASDAQ – trading at $3.14 on volume of 144, 848 shares. The railway safety company priced its small-cap IPO at […]

AN2 Therapeutics (ANTX), a clinical biotech, jumped into the first trading day of spring 2022 by launching its IPO early Monday morning (March 21) for pricing on Thursday night. Shares of AN2 Therapeutics popped on Friday (March 25), opening at $16.85 – up 12.3 percent from their IPO price at $15 – on their first […]

Akanda Corp. (AKAN proposed), a small medical cannabis company, soared in its NASDAQ debut on Tuesday (March 15, 2022) – opening at $30 – or 7.5 times its $4 IPO price. The Akanda deal was the first traditional IPO of March 2022 – braving the market’s chilly waters at a time when Wall Street was […]

Four SPACs – and no IPOs – got done in the first week of March. The world watched in horror after Russian military forces attacked a nuclear plant in southeastern Ukraine on Thursday night (March 3, 2022). The attack provoked fear of a meltdown “that could dwarf the world’s worst nuclear disaster, at Ukraine’s Chernobyl […]

March is off to a subdued start with only 1 SPAC – Valuence Merger Corp. I (VMCAU) – making its trading debut today as all eyes are on Russia’s escalation of attacks on Ukraine. U.S. stocks opened lower and extended their decline by midday, following their drop on Monday (Feb. 28), the first trading day after […]